✦ LIBER ✦

Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates

✍ Scribed by Fizazi, K.; Lipton, A.; Mariette, X.; Body, J.-J.; Rahim, Y.; Gralow, J. R.; Gao, G.; Wu, L.; Sohn, W.; Jun, S.

Book ID: 126919411
Publisher: American Society of Clinical Oncology
Year: 2009
Tongue: English
Weight: 235 KB
Volume: 27
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2008.19.2146

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence of acute phase adverse events

Incidence of acute phase adverse events following denosumab or intravenous bisphosphonates: results from a randomized, controlled phase II study in patients with breast cancer and bone metastases

✍ Cynthia Campbell-Baird; Allan Lipton; Makan Sarkeshik; Haijun Ma; Susie Jun 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 131 KB

Denosumab Treatment of Prostate Cancer W

Denosumab Treatment of Prostate Cancer With Bone Metastases and Increased Urine N-Telopeptide Levels After Therapy With Intravenous Bisphosphonates: Results of a Randomized Phase II Trial

✍ Fizazi, Karim; Bosserman, Linda; Gao, Guozhi; Skacel, Tomas; Markus, Richard 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 383 KB

Denosumab Treatment of Prostate Cancer W

Denosumab Treatment of Prostate Cancer With Bone Metastases and Increased Urine N-Telopeptide Levels After Therapy With Intravenous Bisphosphonates: Results of a Randomized Phase II Trial

✍ Fizazi, Karim; Bosserman, Linda; Gao, Guozhi; Skacel, Tomas; Markus, Richard 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 284 KB

Utilization of intravenous bisphosphonat

Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer

✍ Hagiwara, May; Delea, Thomas E.; Cong, Ze; Chung, Karen 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 231 KB

Denosumab versus zoledronic acid in pati

Denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer: Results from a phase 3 randomized trial

✍ J. Brown*; M. Carducci; K. Fizazi; M. Smith; R. Damião; L. Karsh; P. Milecki; H. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Delayed progression of bone metastases w

Delayed progression of bone metastases with bisphosphonate therapy: a randomised phase III trial with intravenous Aredia (pamidronate disodium) in breast cancer patients

✍ P.F. Conte; J. Latreille; L. Mauriac; L. Koliren; F. Calabresi; J.M. Ford 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 149 KB